These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
653 related articles for article (PubMed ID: 30614823)
1. Beneficial effect of ticagrelor on microvascular perfusion in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention. Wang X; Li X; Wu H; Li R; Liu H; Wang L; Bai S; Zhang L; Chen T; Liu J; Li Q; Du R Coron Artery Dis; 2019 Aug; 30(5):317-322. PubMed ID: 30614823 [TBL] [Abstract][Full Text] [Related]
2. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809 [TBL] [Abstract][Full Text] [Related]
3. Switching from ticagrelor to clopidogrel in patients with ST-segment elevation myocardial infarction undergoing successful percutaneous coronary intervention in real-world China: Occurrences, reasons, and long-term clinical outcomes. Li XY; Su GH; Wang GX; Hu HY; Fan CJ Clin Cardiol; 2018 Nov; 41(11):1446-1454. PubMed ID: 30225843 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction). Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B; Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Microvascular Injury in Revascularized Patients With ST-Segment-Elevation Myocardial Infarction Treated With Ticagrelor Versus Prasugrel. van Leeuwen MAH; van der Hoeven NW; Janssens GN; Everaars H; Nap A; Lemkes JS; de Waard GA; van de Ven PM; van Rossum AC; Ten Cate TJF; Piek JJ; von Birgelen C; Escaned J; Valgimigli M; Diletti R; Riksen NP; van Mieghem NM; Nijveldt R; van Royen N Circulation; 2019 Jan; 139(5):636-646. PubMed ID: 30586720 [TBL] [Abstract][Full Text] [Related]
6. No Benefit of Ticagrelor Pretreatment Compared With Treatment During Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Koul S; Smith JG; Götberg M; Omerovic E; Alfredsson J; Venetsanos D; Persson J; Jensen J; Lagerqvist B; Redfors B; James S; Erlinge D Circ Cardiovasc Interv; 2018 Mar; 11(3):e005528. PubMed ID: 29870381 [TBL] [Abstract][Full Text] [Related]
7. Intracoronary administration of different doses of anisodamine in primary percutaneous coronary intervention: protective effect in patients with ST-segment elevation myocardial infarction. Bai S; Fu X; Gu X; Wang Y; Li W; Fan Y; Wei L; Bi X Coron Artery Dis; 2016 Jun; 27(4):302-10. PubMed ID: 26945186 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of intracoronary verapamil versus sodium nitroprusside for the prevention of microvascular obstruction during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Abdelaziz HK; Elkilany W; Khalid S; Sabet S; Saad M Coron Artery Dis; 2017 Jan; 28(1):11-16. PubMed ID: 27556348 [TBL] [Abstract][Full Text] [Related]
9. Effect of prasugrel versus ticagrelor on coronary microcirculation in patients undergoing pharmacoinvasive strategy - acute and short-term results. Agrawal RS; Yusuf J; Mahajan B; Mehta V; Mandal S; Mukhopadhyay S Coron Artery Dis; 2023 Sep; 34(6):381-388. PubMed ID: 37471285 [TBL] [Abstract][Full Text] [Related]
10. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ Analysis. Montalescot G; van 't Hof AW; Bolognese L; Cantor WJ; Cequier A; Chettibi M; Collet JP; Goodman SG; Hammett CJ; Huber K; Janzon M; Lapostolle F; Lassen JF; Licour M; Merkely B; Salhi N; Silvain J; Storey RF; Ten Berg JM; Tsatsaris A; Zeymer U; Vicaut E; Hamm CW; JACC Cardiovasc Interv; 2016 Apr; 9(7):646-56. PubMed ID: 26952907 [TBL] [Abstract][Full Text] [Related]
11. Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study. You J; Li H; Guo W; Li J; Gao L; Wang Y; Geng L; Wang X; Wan Q; Zhang Q Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():598-605. PubMed ID: 31957972 [TBL] [Abstract][Full Text] [Related]
12. Intracoronary compared with intravenous bolus tirofiban on the microvascular obstruction in patients with STEMI undergoing PCI: a cardiac MR study. Ma Q; Ma Y; Wang X; Li S; Yu T; Duan W; Wu J; Wen Z; Jiao Y; Sun Z; Hou Y Int J Cardiovasc Imaging; 2020 Jun; 36(6):1121-1132. PubMed ID: 32078096 [TBL] [Abstract][Full Text] [Related]
13. Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial. Fabris E; Van't Hof A; Hamm CW; Lapostolle F; Lassen JF; Goodman SG; Ten Berg JM; Bolognese L; Cequier A; Chettibi M; Hammett CJ; Huber K; Janzon M; Merkely B; Storey RF; Zeymer U; Cantor WJ; Kerneis M; Diallo A; Vicaut E; Montalescot G; Catheter Cardiovasc Interv; 2019 Jun; 93(7):E369-E377. PubMed ID: 30302940 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of intracoronary versus intravenous high-dose bolus administration of tirofiban in diabetic patients undergoing primary percutaneous coronary intervention. Ghonim AA; Mostafa A; Emara A; Algazzar AS; Qutub MA Cardiovasc J Afr; 2019 Sep/Oct 23; 30(5):285-289. PubMed ID: 31194213 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994 [TBL] [Abstract][Full Text] [Related]
17. Therapy with ticagrelor for ST-elevated acute coronary syndrome accompanied by diabetes mellitus. Liu Y; Ding LY; Li XZ Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):312-318. PubMed ID: 31389599 [TBL] [Abstract][Full Text] [Related]
18. Influence of intravenous fentanyl compared with morphine on ticagrelor absorption and platelet inhibition in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the PERSEUS randomized trial. Degrauwe S; Roffi M; Lauriers N; Muller O; Masci PG; Valgimigli M; Iglesias JF Eur Heart J Cardiovasc Pharmacother; 2019 Jul; 5(3):158-163. PubMed ID: 30101278 [TBL] [Abstract][Full Text] [Related]
19. Effect of preoperative loading dose ticagrelor and clopidogrel on no-reflow phenomenon during intervention in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis. Dai W; Ye Z; Li L; Su Q Drug Des Devel Ther; 2018; 12():2039-2049. PubMed ID: 30013323 [TBL] [Abstract][Full Text] [Related]